1 April 2024 false No description of principal activity Taxfiler 2024.6 07172495business:PrivateLimitedCompanyLtd2024-04-012025-03-31 071724952024-03-31 071724952024-04-012025-03-31 07172495business:AuditExemptWithAccountantsReport2024-04-012025-03-31 07172495business:FilletedAccounts2024-04-012025-03-31 071724952025-03-31 07172495business:Director12024-04-012025-03-31 07172495business:RegisteredOffice2024-04-012025-03-31 071724952024-03-31 07172495core:WithinOneYear2025-03-31 07172495core:WithinOneYear2024-03-31 07172495core:AfterOneYear2025-03-31 07172495core:AfterOneYear2024-03-31 07172495core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 07172495core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 07172495core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 07172495core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 07172495core:PreviouslyStatedAmount2025-03-31 07172495core:PreviouslyStatedAmount2024-03-31 07172495business:SmallEntities2024-04-012025-03-31 07172495countries:EnglandWales2024-04-012025-03-31 07172495core:PlantMachinery2024-04-012025-03-31 07172495core:MotorVehicles2024-04-012025-03-31 07172495core:PlantMachinery2024-03-31 07172495core:MotorVehicles2024-03-31 07172495core:PlantMachinery2025-03-31 07172495core:MotorVehicles2025-03-31 07172495business:Director112024-04-012025-03-31 07172495business:Director112024-03-31 07172495business:Director112025-03-31 07172495business:Director122024-04-012025-03-31 07172495business:Director122024-03-31 07172495business:Director122025-03-31 071724952023-04-012024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 07172495 (England and Wales)
Vascular Science Ltd Unaudited accounts for the year ended 31 March 2025
Vascular Science Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Vascular Science Ltd Company Information for the year ended 31 March 2025
Director
S K Qureshi
Company Number
07172495 (England and Wales)
Registered Office
193 Greyhound Road London W14 9SD England
Accountants
Lester Associates Limited 105 Palewell Park London SW14 8JJ
- 3 -
Vascular Science Ltd Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
4
45,724 
60,965 
Current assets
Debtors
5
218,373 
199,340 
Cash at bank and in hand
58,618 
71,916 
276,991 
271,256 
Creditors: amounts falling due within one year
6
(139,740)
(116,541)
Net current assets
137,251 
154,715 
Total assets less current liabilities
182,975 
215,680 
Creditors: amounts falling due after more than one year
7
(72,379)
(89,263)
Net assets
110,596 
126,417 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
110,496 
126,317 
Shareholders' funds
110,596 
126,417 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 November 2025 and were signed on its behalf by
S K Qureshi Director Company Registration No. 07172495
- 4 -
Vascular Science Ltd Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Vascular Science Ltd is a private company, limited by shares, registered in England and Wales, registration number 07172495. The registered office is 193 Greyhound Road, London, W14 9SD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
These financial statements for the year ended 31 March 2025 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 April 2023. The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously. The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% reducing balance
Motor vehicles
25% reducing balance
4
Tangible fixed assets
Plant & machinery 
Motor vehicles 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 April 2024
35,019 
58,845 
93,864 
At 31 March 2025
35,019 
58,845 
93,864 
Depreciation
At 1 April 2024
29,167 
3,732 
32,899 
Charge for the year
1,463 
13,778 
15,241 
At 31 March 2025
30,630 
17,510 
48,140 
Net book value
At 31 March 2025
4,389 
41,335 
45,724 
At 31 March 2024
5,852 
55,113 
60,965 
- 5 -
Vascular Science Ltd Notes to the Accounts for the year ended 31 March 2025
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
13,635 
57,876 
Other debtors
62,308 
64,334 
75,943 
122,210 
Amounts falling due after more than one year
Other debtors
142,430 
77,130 
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
10,556 
10,556 
Obligations under finance leases and hire purchase contracts
6,919 
6,919 
Trade creditors
46,299 
47,812 
Taxes and social security
73,262 
51,254 
Other creditors
2,704 
- 
139,740 
116,541 
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
32,968 
42,933 
Obligations under finance leases and hire purchase contracts
39,411 
46,330 
72,379 
89,263 
8
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
S K Qureshi
Director's loan
102,130 
- 
25,000 
77,130 
Director's loan
- 
65,300 
- 
65,300 
102,130 
65,300 
25,000 
142,430 
9
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 6 -